MEDGENERA | NIH to Decide the Fate of Revolutionary Gene Editing Technology

National Institutes of Health (NIH)’s Recombinant DNA Advisory Committee (RAC) will review the decision of using the CRISPR/Cas9 technology for the first-in-human use for gene editing.http://medgenera.com/2016/06/21/nih-to-decide-the-fate-of-revolutionary-gene-editing-crispr-technology/
Like what you read? Give medgenera.com a round of applause.

From a quick cheer to a standing ovation, clap to show how much you enjoyed this story.